KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to $39.4 billion.

  • AbbVie's Total Current Liabilities fell 852.49% to $39.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $39.4 billion, marking a year-over-year decrease of 852.49%. This contributed to the annual value of $38.7 billion for FY2024, which is 239.95% up from last year.
  • AbbVie's Total Current Liabilities amounted to $39.4 billion in Q3 2025, which was down 852.49% from $39.8 billion recorded in Q2 2025.
  • In the past 5 years, AbbVie's Total Current Liabilities ranged from a high of $43.1 billion in Q3 2024 and a low of $27.6 billion during Q1 2023
  • For the 5-year period, AbbVie's Total Current Liabilities averaged around $35.1 billion, with its median value being $34.8 billion (2023).
  • Per our database at Business Quant, AbbVie's Total Current Liabilities surged by 9398.34% in 2021 and then crashed by 1607.09% in 2022.
  • Quarter analysis of 5 years shows AbbVie's Total Current Liabilities stood at $35.2 billion in 2021, then dropped by 16.07% to $29.5 billion in 2022, then rose by 28.11% to $37.8 billion in 2023, then grew by 2.4% to $38.7 billion in 2024, then rose by 1.66% to $39.4 billion in 2025.
  • Its Total Current Liabilities was $39.4 billion in Q3 2025, compared to $39.8 billion in Q2 2025 and $36.4 billion in Q1 2025.